May 2023

The Rajiv Gandhi Centre for Biotechnology is an autonomous national institute of the Government of India, Ministry for Science & Technology, Department of Biotechnology. The mandate of the institute is discovery, innovation and translation in biotechnology and disease biology. At RGCB, our todays are committed to making discoveries that lead to a better tomorrow. RGCB prides itself for innovative research that integrates theory, modeling, simulation, experimental translational and clinical sciences.

WISE Internship in IPR (WISE-IPR)

Panacea Biotec is a leading research based Health Management Company, with an annual turnover of approx. Rs. 830 Crores. We are engaged in research, development, manufacture & marketing of Vaccines, Bio-Pharmaceuticals and Pharmaceuticals (Rx & OTC) of international quality and Health Services. All Panacea Biotec plants are accredited by international agencies and they follow current Good Manufacturing Practices, as per WHO guidelines.

Post : Medical Representative

Vital Pharma is an endeavour to offer trustworthy partnership comprising superior quality products and services par excellence in Contract Manufacturing, Animal Nutrition, Human Nutrition, Aquaculture and Vitamin pre-mixes. Vital Therapeutics & Formulations is designed to meet International Regulatory requirements such as CGMP, WHO, ISO 9001 & FSSC 22000 and recognised for abiding to vigorous quality and service standards for product development, analytical services, packaging and regulatory services.

Panacea Biotec is a leading research based Health Management Company, with an annual turnover of approx. Rs. 830 Crores. We are engaged in research, development, manufacture & marketing of Vaccines, Bio-Pharmaceuticals and Pharmaceuticals (Rx & OTC) of international quality and Health Services. All Panacea Biotec plants are accredited by international agencies and they follow current Good Manufacturing Practices, as per WHO guidelines.

Post : Medical Representative

Troikaa Pharma is a leading company with the remarkable ability to constantly innovate through creative Imagination. Our NDDS brands Dynapar AQ and Dynapar QPS are path breaking & have revolutionised pain care. The company is driven by a visionary leadership and a strong multicultural workforce representing more than 85 countries. It's state-of-the-art manufacturing facilities located at Thol, Dehradun and Sanand are accredited by global authorities including WHO, PIC/S, ANVISA Brazil, INVIMA & several other regulatory authorities.

At BaseSolve, we are transforming Genomics Data Science Technologies. We provide smart solutions for efficient analysis and management of Next Generation Sequencing data facilitating accurate insights for clinical diagnostics as well as scientific research.

Post : Sr Bioinformatics Scientist (2 positions)

FDA halts clinical trials of Deuruxolitinib due to the potential for thrombotic events seen in subjects. FDA has placed the IND on partial clinical hold and are requiring that subjects currently on studies to discontinue the dose.

It has been noted by the FDA that pulmonary embolism (Serious Adverse Events) occurring at the 12 mg BID dose in one of the long-term Open Label Extension (OLE) studies of Deuruxolitinib.

Astellas Pharma Inc and Pfizer Inc announced that XTANDI® (enzalutamide) plus leuprolide significantly reduced the risk of metastasis or death by 58% versus placebo plus leuprolide (Hazard Ratio [HR]: 0.42; 95% Confidence Interval [CI], 0.30–0.61; P<0.0001), as assessed by the primary endpoint of metastasis-free survival (MFS), in men with non-metastatic hormone-sensitive prostate cancer (nmHSPC; also known as non-metastatic castration-sensitive prostate cancer or nmCSPC) with high-risk biochemical recurrence (BCR).